Vimarsana
Biggest News Aggregation in the World

Page 3 - Nasdaq Coll News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Coll. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Coll Today - Breaking & Trending Today

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) CEO Sells $435,915.48 in Stock - Vimarsana News

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) CEO Sells $435,915.48 in Stock

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) CEO Joseph Ciaffoni sold 14,516 shares of the company’s stock in a transaction on Tuesday, December 19th. The stock was sold at an average price of $30.03, for a total transaction of $435,915.48. Following the completion of the transaction, the chief executive officer now directly owns 275,000 […]

Collegium Pharmaceutical (NASDAQ:COLL) Upgraded at StockNews.com - Vimarsana News

Collegium Pharmaceutical (NASDAQ:COLL) Upgraded at StockNews.com

StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a report issued on Wednesday morning. Separately, Needham & Company LLC raised their price target on Collegium Pharmaceutical from $35.00 to $36.00 and gave the stock a buy rating in a research report on Friday, August […]

Collegium Pharmaceutical (NASDAQ:COLL) Upgraded to Strong-Buy by StockNews.com - Vimarsana News

Collegium Pharmaceutical (NASDAQ:COLL) Upgraded to Strong-Buy by StockNews.com

StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Wednesday. Separately, Needham & Company LLC increased their price objective on Collegium Pharmaceutical from $35.00 to $36.00 and gave the stock a buy rating in a research note on […]

Collegium Pharmaceutical (NASDAQ:COLL) Cut to Buy at StockNews.com - Vimarsana News

Collegium Pharmaceutical (NASDAQ:COLL) Cut to Buy at StockNews.com

StockNews.com downgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a strong-buy rating to a buy rating in a research note released on Tuesday morning. Separately, Needham & Company LLC increased their price target on Collegium Pharmaceutical from $35.00 to $36.00 and gave the company a buy rating in a research report on Friday, […]

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Short Interest Down 7.3% in October - Vimarsana News

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Short Interest Down 7.3% in October

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) saw a large drop in short interest during the month of October. As of October 31st, there was short interest totalling 6,010,000 shares, a drop of 7.3% from the October 15th total of 6,480,000 shares. Approximately 17.8% of the shares of the company are short sold. Based […]